Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 94-95, 53-66
Abstract
No abstract availableKeywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Progress and challenges towards targeted delivery of cancer therapeuticsNature Communications, 2018
- Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery SystemsPharmaceutics, 2017
- Deregulation of cell signaling in cancerFEBS Letters, 2014
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biologyAdvanced Drug Delivery Reviews, 2014
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdvanced Drug Delivery Reviews, 2011
- Nanotargeted Radionuclides for Cancer Nuclear Imaging and Internal RadiotherapyJournal of Biomedicine and Biotechnology, 2010
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicityCoordination Chemistry Reviews, 2005
- SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapyAdvanced Drug Delivery Reviews, 2001